Comparison

Anti-Recombinant-SARS-CoV-2 Nucleocapsid protein antibody [22F9] (STJA0002890) European Partner

Item no. STJA0002890-500
Manufacturer St John's Laboratory
Amount 500 ug
Quantity options 100 ug 1000 ug 500 ug
Applications WB, ELISA
Clone 22F9
Specific against SARS-CoV-2
Host Human
Isotype IgG1 Lambda
Conjugate/Tag Unconjugated
Available
Manufacturer - Type
Primary antibodies
Storage Conditions
Store at-20 °C to-70 °C long term. Avoid multiple freeze-thaw cycles.
Formulation
PBS pH 7.4
Purification
Protein A affinity chromatography
Immunogen
Recombinant SARS-CoV-2 Nucleocapsid protein produced by CHO-based proprietary suspension cell line. Nucleocapsid protein SARS-CoV-2
Clonality
Monoclonal
Dilution range
ELISA 0.08-0.16 µg/ml
Note
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Manufacturer - Specificity
SARS-CoV-2 Nucleocapsid protein
Dissociation Constant
< 1.0 x 10-12 M

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close